- Requires certain health care providers who have prescriptive authority to complete substance use disorder training as part of continuing education required to renew the provider's license. Specifically, the requirement applies to podiatrists, dentists, advanced practice nurses, optometrists, and veterinarians ( section 12).
- Prohibits a physician or physician assistant from accepting any direct or indirect benefits for prescribing a specific medication ( section 2 );
- Requires the state board of pharmacy to promulgate rules that require a prescription for an opioid for outpatient use, except for an opioid prescribed for treatment of a substance use disorder or that is a partial opioid antagonist, to bear a warning label ( section 3 );
- Allows medical examiners and coroners access to the prescription drug monitoring program under specified circumstances ( section 4 );
- For the 2019-20 fiscal year, appropriates $2 million to the department of public health and environment for the purpose of working at state and local levels to address opioid and other substance use disorder priorities ( section 6 );
- Requires specified state departments to report to the health committees of the general assembly by December 31, 2019, the amount of federal funds that each is receiving or is eligible to receive for use in testing for hepatitis and HIV and the number of individuals currently and anticipated to be tested. The departments are also required to share eligibility standards for treatment with primary care providers ( section 7 ).
- Creates a grant program in the office of behavioral health in the department of human services to address opioid and other substance use disorder prevention and recovery. The grant focuses on at-risk youth and their families affected by substance use disorders and who have not been successful in seeking aid through existing resources. The general assembly is required to appropriate $2 million from the marijuana tax cash fund to the department of human services ( section 8 ).
- Requires the center for research into substance use disorder prevention, treatment, and recovery support strategies (center) to develop and implement a program to increase public awareness about the safe use, storage, and disposal of opioids, and about the availability of antagonist drugs. The general assembly is required to annually appropriate $750,000 to the center from the marijuana tax cash fund to implement the program ( section 9 ).
- Requires the center to hire additional staff to assist local communities in applying for grants, and requires the general assembly to appropriate general funds for the 2019-20 fiscal year to enable the center to hire staff for this purpose ( section 9 );
- Requires the office of behavioral health in the department of human services to administer a pilot program to integrate substance use disorder and medication-assisted treatment with obstetric and gynecological health care and requires the general assembly to appropriate money from the general fund in the 2019-20, 2020-21, and 2021-22 fiscal years to fund the pilot program ( section 11 ).
Sections 12 through 15 make conforming amendments to harmonize the bill with the title 12 recodification bill, House Bill 19-1172.
(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)